A Mito-targeted, pH-sensitive type I photosensitizer for the diagnosis and therapy in bone metastasis of triple negative breast cancer by activating pyroptosis pathway
Ya-Xi Ye , Jian-Cheng Pan , Yu Jiang , Pei Tang , Hai-Chao Wang , Xin-Ai Shi , Xing-Tao Zhang , Hai-Liang Zhu , Xin-Hua Liu
{"title":"A Mito-targeted, pH-sensitive type I photosensitizer for the diagnosis and therapy in bone metastasis of triple negative breast cancer by activating pyroptosis pathway","authors":"Ya-Xi Ye , Jian-Cheng Pan , Yu Jiang , Pei Tang , Hai-Chao Wang , Xin-Ai Shi , Xing-Tao Zhang , Hai-Liang Zhu , Xin-Hua Liu","doi":"10.1016/j.bios.2025.117559","DOIUrl":null,"url":null,"abstract":"<div><div>Rational design of multifunctional molecules integrating diagnostic and therapeutic capabilities represents a cutting-edge yet challenging frontier in modern medicine. In this study, we present the first report on <strong>Rh-HB</strong>, a smart near-infrared (NIR) molecular probe engineered for mitochondria-targeted theranostics in triple-negative breast cancer (TNBC) bone metastasis. As a ratiometric, dual-excitation pH-sensitive fluorescent probe, <strong>Rh-HB</strong> enables real-time monitoring of mitochondrial pH fluctuations associated with early-stage metastatic progression. Moreover, <strong>Rh-HB</strong> functions as a highly efficient type I photosensitizer, generating cytotoxic reactive oxygen species (ROS) such as superoxide anion (O<sub>2</sub><sup>•-</sup>) and hydroxyl radicals (·OH) upon light irradiation within mitochondria. This localized ROS production overcomes the limitations of short diffusion distances, ensuring effective oxidative damage. Crucially, <strong>Rh-HB</strong> induces severe mitochondrial oxidative stress, triggering pyroptosis in TNBC bone metastasis models. Thus, <strong>Rh-HB</strong> serves as a proof-of-concept theranostic agent, offering a promising strategy for combating bone metastasis of TNBC.</div></div>","PeriodicalId":259,"journal":{"name":"Biosensors and Bioelectronics","volume":"283 ","pages":"Article 117559"},"PeriodicalIF":10.7000,"publicationDate":"2025-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biosensors and Bioelectronics","FirstCategoryId":"1","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0956566325004336","RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOPHYSICS","Score":null,"Total":0}
引用次数: 0
Abstract
Rational design of multifunctional molecules integrating diagnostic and therapeutic capabilities represents a cutting-edge yet challenging frontier in modern medicine. In this study, we present the first report on Rh-HB, a smart near-infrared (NIR) molecular probe engineered for mitochondria-targeted theranostics in triple-negative breast cancer (TNBC) bone metastasis. As a ratiometric, dual-excitation pH-sensitive fluorescent probe, Rh-HB enables real-time monitoring of mitochondrial pH fluctuations associated with early-stage metastatic progression. Moreover, Rh-HB functions as a highly efficient type I photosensitizer, generating cytotoxic reactive oxygen species (ROS) such as superoxide anion (O2•-) and hydroxyl radicals (·OH) upon light irradiation within mitochondria. This localized ROS production overcomes the limitations of short diffusion distances, ensuring effective oxidative damage. Crucially, Rh-HB induces severe mitochondrial oxidative stress, triggering pyroptosis in TNBC bone metastasis models. Thus, Rh-HB serves as a proof-of-concept theranostic agent, offering a promising strategy for combating bone metastasis of TNBC.
期刊介绍:
Biosensors & Bioelectronics, along with its open access companion journal Biosensors & Bioelectronics: X, is the leading international publication in the field of biosensors and bioelectronics. It covers research, design, development, and application of biosensors, which are analytical devices incorporating biological materials with physicochemical transducers. These devices, including sensors, DNA chips, electronic noses, and lab-on-a-chip, produce digital signals proportional to specific analytes. Examples include immunosensors and enzyme-based biosensors, applied in various fields such as medicine, environmental monitoring, and food industry. The journal also focuses on molecular and supramolecular structures for enhancing device performance.